IRCT201710241556N100招募中2 期
Vortioxetine as adjunctive treatment of negative symptoms in patients with schizophrenia: a double blind and placebo controlled trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •1-Diagnosis of Schizophrenia based on DSM-5 criteria; 2- Age between 18-60; 3-Chronic Schizophrenia- duration of the disorder more than 2 years; 4-Minimum score of 20 in negative sub score. 5-being stable on risperidone for the last 2 months. Exclusion criteria:1-Any serious medical or neurological problem; 2- IQ less than 70; 3- Substance dependence during the last 6 months(except for nicotine and caffeine); 4- Score on HDRS less than 14 5-receiving ECT during the last 3 months ; 6-Acute or chronic systemic diseases; 7- History of neurosurgery; 8- History of head trauma.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Duloxetine in patients with schizophreniaschizophreniaschizophrenia.IRCT201506201556N77Tehran University of Medical Sciences50
已完成
3 期
Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive DisorderMajor Depressive DisorderNCT02279953H. Lundbeck A/S151
尚未招募
2 期
A randomized placebo-controlled trial of vortioxetine for obsessive-compulsive disorderCTRI/2023/12/060748Indican Council of Medical Research
招募中
不适用
Relationship between the effects of vortioxetine and sleep EEG findings in depressioDepressionJPRN-UMIN000047036ihon University Itabashi Hospital30
Unknown
2 期
Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar DepressionBipolar Disorder DepressionNCT03598868Seoul National University Hospital100